April 13, 2026
Neomorph
Neomorph develops protein degradation therapies targeting...
- Round
- Series B
- Amount raised
- $100M
- Lead investor
- Deerfield
- Industry
- Biotechnology
- Headquarters
- San Diego, United States
- Employees
- 101-250
- Website
- neomorph.com
- —
April 13, 2026
Neomorph develops protein degradation therapies targeting...